✦ LIBER ✦

PCN73 USING SHORT-TERM RESPONSE TO PREDICT LONG-TERM OUTCOMES IN PATIENTS WITH IMATINIB-RESISTENT OR IMATINIB-INTOLERANT CHRONIC MYELOID LEUKAEMIA

✍ Scribed by M Taylor; R Saxby; C Davis

Book ID: 118610908
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 88 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)73310-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Significance of suboptimal response to i

Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long-term outcome of patients with early chronic myeloid leukemia in chronic phase

✍ Yesid Alvarado; Hagop Kantarjian; Susan O'Brien; Stefan Faderl; Gautam Borthakur 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 2 views

## Abstract ## BACKGROUND: The European LeukemiaNet recommendations for chronic myeloid leukemia (CML) defined a group of patients with suboptimal response to imatinib. The significance of this response was not well defined. ## METHODS: The significance of having had a suboptimal response during

PCN48 NON-ADHERENCE TO IMATINIB IN CHRON

PCN48 NON-ADHERENCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS IS ASSOCIATED WITH SHORT- AND LONG-TERM NEGATIVE IMPACTS ON HEALTH CARE RESOURCE UTILIZATION AND COSTS

✍ A Guerin; V Bollu; A Guo; EQ Wu; AP Yu; LA Sirulnik; JD Griffin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB